Mark Ward
Impact in
-
- Neuroscience and Neuropharmacology Research
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
Papers in
-
- Neuroscience and Neuropharmacology Research 17
- Physiology 12
- Nitric Oxide and Endothelin Effects 5
- Alzheimer's disease research and treatments 4
- Co-authors
- Michael J. O’Neill (21 shared papers)Caroline Hicks (18 shared papers)Junru Wu (2 shared papers)Jen‐Fu Chiu (2 shared papers)Tracey K. Murray (9 shared papers)Ann Bond (4 shared papers)David Lodge (5 shared papers)Joan E. Shook (2 shared papers)
- Journals
- European Journal of Pharmacology (8 papers)Brain Research (6 papers)Academic Pediatrics (5 papers)Pediatric Emergency Care (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Mark Ward
73 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 159
- Cellular and Molecular Neuroscience 946
- Neurology 359
- Developmental Neuroscience 132
- Emergency Medicine 250
- Physiology 565
Countries citing papers authored by Mark Ward
This map shows the geographic impact of Mark Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ward more than expected).
Fields of papers citing papers by Mark Ward
This network shows the impact of papers produced by Mark Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ward. The network helps show where Mark Ward may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 373 | |
| 2 | 1999 | 260 | |
| 3 | 1999 | 161 | |
| 4 | 2000 | 160 | |
| 5 | 1998 | 100 | |
| 6 | 2003 | 93 | |
| 7 | 2002 | 87 | |
| 8 | 2000 | 87 | |
| 9 | 1999 | 85 | |
| 10 | 1998 | 77 | |
| 11 | 1999 | 68 | |
| 12 | 1996 | 65 | |
| 13 | 2007 | 60 | |
| 14 | 2004 | 56 | |
| 15 | 2000 | 55 | |
| 16 | 1996 | 54 | |
| 17 | 2004 | 49 | |
| 18 | 2017 | 49 | |
| 19 | 2016 | 48 | |
| 20 | 2000 | 44 |
About Mark Ward
Mark Ward is a scholar working on Cellular and Molecular Neuroscience, Physiology, Neurology, Public Health, Environmental and Occupational Health and Emergency Medicine, having authored 78 papers that have together received 2.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (17 papers), Neurological Disease Mechanisms and Treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Innovations in Medical Education (6 papers), Nitric Oxide and Endothelin Effects (5 papers), Alzheimer's disease research and treatments (4 papers), Electron Spin Resonance Studies (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (946 citations), Neurology (359 citations), Developmental Neuroscience (132 citations), Emergency Medicine (250 citations) and Physiology (565 citations). Mark Ward has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Michael J. O’Neill, Caroline Hicks, Junru Wu, Jen‐Fu Chiu, Tracey K. Murray, Ann Bond, David Lodge, Joan E. Shook, Paul E. Sirbaugh and Mitchell J. Goldman. Their work appears in journals such as European Journal of Pharmacology, Brain Research, Academic Pediatrics, Pediatric Emergency Care and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.